Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2012; 18(10): 1048-1058
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1048
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1048
Figure 2 Identification of mesenchymal stem cell transdifferentiation into hepatocytes.
Hepatocytes were used as positive control. A: Fluorescence immunostaining detection of α-fetoprotein (AFP) expression after 21 d induction in mesenchymal stem cells (MSCs) (10 × 40 magnification); B: Fluorescence immunostaining detection of albumin expression after 21 d induction in MSCs (10 × 40 magnification); C: Reverse transcription polymerase chain reaction detection of hepatocyte specific protein AFP, albumin and cytokeratin 18 (CK18) mRNA expression after 7, 14 and 21 d induction in MSCs. Scale bars represents 100 mm.
- Citation: Zhao W, Li JJ, Cao DY, Li X, Zhang LY, He Y, Yue SQ, Wang DS, Dou KF. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol 2012; 18(10): 1048-1058
- URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1048.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i10.1048